ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SREELATHA NAIR MD

2027 LEBANON CHURCH RD CENTURY III MEDICAL ASSOCIATES

West mifflin | Pennsylvania | 15122

(412) 655-6403

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 818 out of 2343

$399K Total Retail Price of All Prescriptions

Rank: 907 out of 2343

413 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 5,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 626 465 1 1
LISINOPRIL 369 241 2 3
OMEPRAZOLE 303 219 3 4
LEVOTHYROXINE SODIUM 294 215 4 2
METOPROLOL TARTRATE 246 217 5 7
HYDROCODONE-ACETAMINOPHEN 179 127 S3 6 13
METFORMIN HCL 154 113 7 9
CITALOPRAM HBR 144 122 8 17
FUROSEMIDE 135 116 9 6
ATENOLOL 122 100 10 12
GABAPENTIN 118 101 11 16
AMLODIPINE BESYLATE 115 94 12 5
ALENDRONATE SODIUM 109 74 13 28
LOSARTAN POTASSIUM 98 86 14 19
HYDROCHLOROTHIAZIDE 96 74 15 11
POTASSIUM CHLORIDE 96 81 15 18
GLIMEPIRIDE 93 54 17 45
WARFARIN SODIUM 91 77 18 8
METOPROLOL SUCCINATE 87 81 19 14
PRAVASTATIN SODIUM 85 81 20 15
RISPERIDONE 78 0 21 61
QUINAPRIL HCL 78 76 21 73
RANITIDINE HCL 77 59 23 43
PANTOPRAZOLE SODIUM 70 43 24 22
TRIAMTERENE-HCTZ 69 55 25 57
ATORVASTATIN CALCIUM 68 61 26 10
FENOFIBRATE 67 31 27 94
FLUTICASONE PROPIONATE 66 48 28 46
CARVEDILOL 62 61 29 27
DOXAZOSIN MESYLATE 59 47 30 98
MIRTAZAPINE 57 57 31 41
SPIRIVA 56 47 32 48
VENTOLIN HFA 52 25 33 79
ALLOPURINOL 51 51 34 31
FELODIPINE ER 51 51 34 116
LOVASTATIN 50 32 36 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.